(Total Views: 657)
Posted On: 11/22/2017 7:04:18 PM
Post# of 1354
NetworkNewsBreaks – Pressure BioSciences, Inc.’s (PBIO) Q3 Top Line Marks Record Quarterly Growth
Pressure BioSciences (OTCQB: PBIO) capitalized on a strong demand for its proprietary pressure-based laboratory instruments and related products, reporting record quarterly revenues of more than $600,000 for Q32017. An article discussing this reads: “Among recent highlights of the company’s operations, Pressure BioSciences set up its first Center of Excellence in Asia, which should have a marked impact on PBIO’s expansion into China. PBIO’s penetration into Europe is also expected to increase in the wake of multiple scientific presentations made throughout the continent over the past few months, some by key opinion leaders in the proteomics space.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioSciences (OTCQB: PBIO) capitalized on a strong demand for its proprietary pressure-based laboratory instruments and related products, reporting record quarterly revenues of more than $600,000 for Q32017. An article discussing this reads: “Among recent highlights of the company’s operations, Pressure BioSciences set up its first Center of Excellence in Asia, which should have a marked impact on PBIO’s expansion into China. PBIO’s penetration into Europe is also expected to increase in the wake of multiple scientific presentations made throughout the continent over the past few months, some by key opinion leaders in the proteomics space.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)
